Scholars Central

Conference abstractPublished 24 Feb 2023

Medical Cannabis for Alzheimer’s Diseases-Is it An Option?

Authors: Joseph Rosado

Lake Erie College of Osteopathic Medicine, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

BACKGROUND: Alzheimer's disease (AD) is a progressive and irreversible brain disorder that slowly destroys memory and thinking skills and eventually the ability to carry out the simplest tasks. Currently, it ranks as the sixth leading cause of death in the United States and the fourth leading cause of death on the island of Puerto Rico and Colombia. Medical cannabis is now a part of contemporary medicine, with physicians recommending a medical card in 33 states and two territories in the United States of America, for physiological conditions such as vomiting, migraines, multiple sclerosis, glaucoma, nausea, cell disease sickle cell disease, Parkinson's disease, sleep apnea, spinal cord injury, arthritis, Alzheimer's disease, muscle spasms, and asthma, as well as psychological conditions such as anxiety disorder, insomnia, bipolar disorder, depression, and post-traumatic stress disorder. DESIGN/METHODS: A literature review was conducted of the National Center for Biotechnology Information, U.S. National Library of Medicine PubMed from 2001-2019 specific to the topic of Alzheimer’s Disease and Medical Cannabis/Medical Marijuana/CBD/THC. RESULTS: Phytocannabinoid treatment can restore cognition in older animals and induce molecular changes that make them more similar to young animals. CONCLUSION: The inherent polypharmaceutical properties of cannabis botanicals offer distinct advantages over the current single-target pharmaceutical model and heralds revolutionizing neurological treatment into a new reality of effective and even preventative interventional treatment and studies show that cannabis extracts can be used in safe way to improve symptoms of severe dementia.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Joseph Rosado”